Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2022 May 2;13:892656. doi: 10.3389/fphar.2022.892656

Corrigendum: Molecular Docking as a Therapeutic Approach for Targeting Cancer Stem Cell Metabolic Processes

Babak Arjmand 1,*, Shayesteh Kokabi Hamidpour 1, Sepideh Alavi-Moghadam 1, Hanieh Yavari 1, Ainaz Shahbazbadr 1, Mostafa Rezaei-Tavirani 2, Kambiz Gilany 3,4, Bagher Larijani 5,*
PMCID: PMC9108975  PMID: 35586055

In the published article, there was an error in affiliation 3, 4, 5. Instead of “3 Reproductive Immunology Research Center, Avicenna Research Institute (ARI), Tehran, Iran, 4 Department of Biomedical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium, 5 Breast Cancer Research Center, Motamed Cancer Institute, Tehran, Iran”, it should be “3 Integrative Oncology Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran, 4 Reproductive Immunology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran, 5 Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES